Cargando…

Aspirin for the prevention and treatment of pre‐eclampsia: A matter of COX‐1 and/or COX‐2 inhibition?

Since the 1970s, we have known that aspirin can reduce the risk of pre‐eclampsia. However, the underlying mechanisms explaining this risk reduction are poorly understood. Both cyclooxygenase (COX)‐1‐ and COX‐2‐dependent effects might be involved. As a consequence of this knowledge hiatus, the optima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mirabito Colafella, Katrina M., Neuman, Rugina I., Visser, Willy, Danser, A. H. Jan, Versmissen, Jorie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	MINIREVIEWS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496715/ https://www.ncbi.nlm.nih.gov/pubmed/31420920 http://dx.doi.org/10.1111/bcpt.13308

Ejemplares similares

COX inhibitors and breast cancer
por: Mazhar, D, et al.
Publicado: (2006)

Thrombomodulin is upregulated in the kidneys of women with pre-eclampsia
por: van Aanhold, Cleo C. L., et al.
Publicado: (2021)

COX-1, and not COX-2 activity, regulates airway function: relevance to aspirin-sensitive asthma
por: Harrington, Louise S., et al.
Publicado: (2008)

Differential effects of cyclo-oxygenase 1 and 2 inhibition on angiogenesis inhibitor-induced hypertension and kidney damage
por: Mirabito Colafella, Katrina M., et al.
Publicado: (2022)

The role of low-dose aspirin in the prevention of pre-eclampsia
por: Akhigbe, R. E.
Publicado: (2014)

COX-2 and EGFR: Partners in Crime Split by Aspirin
por: Patrignani, Paola, et al.
Publicado: (2015)

The effect of age on blood pressure response by 4‐week treatment perindopril: A pooled sex‐specific analysis of the EUROPA, PROGRESS, and ADVANCE trials
por: Schreuder, Michelle M., et al.
Publicado: (2021)

Impact of Aspirin Supplementation for Pre-Eclampsia Prevention on Neonatal Outcomes
por: Campo, Bertha, et al.
Publicado: (2023)

Association of GPIa and COX‐2 gene polymorphism with aspirin resistance
por: Wang, Hui, et al.
Publicado: (2017)

Application of low dose aspirin in pre-eclampsia
por: Ren, Yu, et al.
Publicado: (2023)

Prediction of pre‐eclampsia‐related complications in women with suspected or confirmed pre‐eclampsia: development and internal validation of clinical prediction model
por: Saleh, L., et al.
Publicado: (2021)

Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?
por: Langley, R E, et al.
Publicado: (2011)

Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention
por: Ornelas, Argentina, et al.
Publicado: (2017)

Expression of COX-1, COX-2, 5-LOX and [Formula: see text] in nasal polyps and bronchial tissue of patients with aspirin exacerbated airway disease
por: Vorsprach, Monique, et al.
Publicado: (2019)

Mechanisms of Colorectal Cancer Prevention by Aspirin—A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways
por: Sankaranarayanan, Ranjini, et al.
Publicado: (2020)

Aspirin Ameliorates Pancreatic Inflammation and Fibrosis by Inhibiting COX-2 Expression in Experimental Chronic Pancreatitis
por: Xu, Xiao-Fan, et al.
Publicado: (2022)

Comment on: The sFlt-1 to PlGF ratio in pregnant women with rheumatoid arthritis: impact of disease activity and sulfasalazine use. Reply
por: Smeele, Hieronymus T W, et al.
Publicado: (2021)

COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders
por: Müller, Norbert
Publicado: (2019)

The mitochondrial TMEM177 associates with COX20 during COX2 biogenesis
por: Lorenzi, Isotta, et al.
Publicado: (2018)

Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertension
por: van Doorn, Leni, et al.
Publicado: (2022)

Aspirin and heparin for the prevention of pre-eclampsia: protocol for a systematic review and network meta-analysis
por: Huang, Jinzhu, et al.
Publicado: (2019)

COX-2 Inhibition by Use of Rofecoxib or High Dose Aspirin Enhances ADP-Induced Platelet Aggregation in Fresh Blood
por: Borgdorff, Piet, et al.
Publicado: (2010)

Select Dietary Phytochemicals Function as Inhibitors of COX-1 but Not COX-2
por: Li, Haitao, et al.
Publicado: (2013)

Pharmacologic Inhibition of COX-1 and COX-2 in Influenza A Viral Infection in Mice
por: Carey, Michelle A., et al.
Publicado: (2010)

Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling()
por: Vannini, Federica, et al.
Publicado: (2015)

The Association of Four Common Polymorphisms from Four Candidate Genes (COX-1, COX-2, ITGA2B, ITGA2) with Aspirin Insensitivity: A Meta-Analysis
por: Weng, Zhiyuan, et al.
Publicado: (2013)

Sir James Coxe
Publicado: (1878)

Dr. Coxe, on Vaccination
por: Coxe, John Redman
Publicado: (1805)

Sir James Coxe
Publicado: (1878)

Dr. Joseph T. Cox
Publicado: (1918)

Bishop Coxe on Science
Publicado: (1869)

Megalin, Proton Pump Inhibitors and the Renin–Angiotensin System in Healthy and Pre-Eclamptic Placentas
por: Sun, Yuan, et al.
Publicado: (2021)

Viscum album-Mediated COX-2 Inhibition Implicates Destabilization of COX-2 mRNA
por: Saha, Chaitrali, et al.
Publicado: (2015)

Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
por: Mukherjee, Debabrata, et al.
Publicado: (2003)

Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A(2)
por: Lucotti, Serena, et al.
Publicado: (2019)

The nonsense-mediated mRNA decay (NMD) pathway differentially regulates COX17, COX19 and COX23 mRNAs
por: Murtha, Kaitlin, et al.
Publicado: (2018)

Aspirin for the Prevention of Early and Severe Pre-Eclampsia Recurrence: A Real-World Population-Based Study
por: Lailler, Grégory, et al.
Publicado: (2023)

Prevention and management of severe pre-eclampsia/eclampsia in Afghanistan
por: Kim, Young Mi, et al.
Publicado: (2013)

COX-2: Where are we in 2003? - Specific cyclooxygenase-2 inhibitors and aspirin-exacerbated respiratory disease
por: Crofford, Leslie J
Publicado: (2003)

Associations of aspirin and other anti-inflammatory medications with breast cancer risk by the status of COX-2 expression
por: Yaghjyan, Lusine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rht4nn3t0pkv9j7o17tmvq6356